Dr. Damodar Reddy Kumbala, MD

Dr. Kumbala practices at Renal Associates of Baton Rouge in Baton Rouge, Louisiana.

Dr. Kumbala's NPI, 1922188390, was assigned on October 17, 2006. Dr. Kumbala holds Louisiana license MD.202414.

Dr. Kumbala's primary practice is Renal Associates of Baton Rouge, at 5131 O'donovan Dr, Baton Rouge, LA 70808 in East Baton Rouge Parish. The practice phone is (225) 767-4893.

Dr. Kumbala's primary practice is Renal Associates of Baton Rouge in Baton Rouge, Louisiana. Dr. Kumbala is also affiliated with Our Lady of the Lake Regional Medical Center. The medical group on file is Ochsner Health. Dmand AI also links Dr. Kumbala to 2 more hospitals, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kumbala practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kumbala's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Kumbala is licensed in Louisiana.

CMS data shows 1,081 Medicare services from Dr. Kumbala across 18 procedure codes in 2024, for 435 Medicare patients. Medicare paid $110,543 for them.

CMS counts 435 Medicare patients who saw Dr. Kumbala in 2024. The largest group is 65 to 74, with 163 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 27% are also on Medicaid. Their average risk score is 4.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kumbala's median patient age at 68, with 51% women.

In 2024, Dr. Kumbala wrote 1,858 Medicare Part D claims for 291 patients. 52% of them were for generic drugs. CMS names the drug for 1,689 of them, across 26 drugs with 11 or more claims each, at $1,195,544 in total drug cost. In 2023, CMS named 1,525 claims across 33 drugs.

Dr. Kumbala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kumbala as offering telehealth.

Dmand AI links 15 papers to Dr. Kumbala, published from 2014 to 2024. 2023 was the busiest year, with 2. The most frequent topics are Diabetes Mellitus, Kidney Failure, Chronic and Renal Insufficiency, Chronic. Dr. Kumbala has published most often in Front Nephrol. Dr. Kumbala's most frequent co-authors are Alexandre Miguel Benjo, MD, Narender Annapureddy, MD and Shirisha Bodana, DO.

CMS Open Payments shows 360 general payments to Dr. Kumbala from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. C. R. Bard, Inc. & Subsidiaries paid the most, $3,055.